美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

24.34

+0.30001.25%

盤後：24.340.00000.00%19:39 EDT

成交量：182.30萬

成交額：4,448.94萬

市值：68.67億

市盈率：65.43

高：24.67

開：24.16

低：24.09

收：24.04

52周最高：34.75

52周最低：14.19

股本：2.82億

流通股本：1.16億

量比：0.42

換手率：1.57%

股息：- -

股息率：- -

每股收益(TTM):0.3720

每股收益(LYR):-3.2200

淨資產收益率：20.13%

總資產收益率：8.77%

市淨率：11.61

市盈率(LYR):-7.56

資料載入中...

總覽公司新聞公告

異動解讀｜Caris Life Sciences盤中下跌5.19%，報26.555美元

異動解讀｜Caris Life Sciences盤中上漲5.01%，報27.44美元

異動解讀｜Caris Life Sciences盤中上漲5.09%，Q2業績大超預期持續推動股價上行

異動解讀｜Caris Life Sciences盤中上漲7.89%，Q2業績大超預期持續推動股價上行

財報前瞻｜Caris Life Sciences, Inc.本季度營收預計增長74.08%，機構觀點偏正面

Caris Life Sciences推出PTEN IHC檢測拓展轉移性前列腺癌精準腫瘤學

环球市场播报

Caris Life Sciences授權1億美元股票回購計劃

环球市场播报

Caris Life Sciences 計劃以可用現金及現金等價物為股票回購計劃提供資金

Caris生命科學向紐約州衞生部提交Caris Assure血液檢測授權申請

Caris生命科學公司Caris Chromoseq獲Moldx批准，推動髓系惡性腫瘤全面基因組圖譜檢測可及性

財報前瞻｜Caris Life Sciences, Inc.本季度營收預計按年持平，看多觀點佔優

華安保險：李雲煥因個人原因辭去公司總經理職務指定CAI ZHENGYUAN為臨時負責人

美國研究綜述-百健、Equinix、Revolution Medicines

美國研究綜述-百健、Equinix、Revolution Medicines

Caris生命科學公司與Blue Owl Capital及黑石集團達成新信貸協議——SEC文件披露

Caris生命科學公司信貸協議披露：4億美元定期貸款、3億美元延遲提款及5億美元增量融資

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/CAI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":24.34,"timestamp":1789156800000,"preClose":24.04,"halted":0,"volume":1822950,"hourTrading":{"tag":"盘后","latestPrice":24.34,"preClose":24.34,"latestTime":"19:39 EDT","volume":60753,"amount":1478758.941,"timestamp":1789169992269,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01247920133111484,"floatShares":115999999,"shares":282146923,"eps":0.372,"marketStatus":"休市中","change":0.3,"latestTime":"09-11 16:00:00 EDT","open":24.16,"high":24.67,"low":24.09,"amount":44489411.9433,"amplitude":0.024126,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.372,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":24.04,"preHourTrading":{"tag":"盘前","latestPrice":24.05,"preClose":24.04,"latestTime":"09:28 EDT","volume":927,"amount":22502.048985,"timestamp":1789133332030,"change":0.01,"changeRate":0.000416,"amplitude":0.011231},"postHourTrading":{"tag":"盘后","latestPrice":24.34,"preClose":24.34,"latestTime":"19:39 EDT","volume":60753,"amount":1478758.941,"timestamp":1789169992269,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.42387677493158393,"impliedVol":0.4636,"impliedVolPercentile":0.0438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","floatShares":115999999,"roa":"8.77%","roe":"20.13%","lyrEps":-3.22,"volumeRatio":0.42387677493158393,"shares":282146923,"dividePrice":0,"high":24.67,"amplitude":0.024126,"preClose":24.04,"low":24.09,"week52Low":14.19,"pbRate":"11.61","psRate":"6.94","week52High":34.75,"institutionHeld":0,"latestPrice":24.34,"eps":0.372,"divideRate":0,"volume":1822950,"delay":0,"ttmEps":0.372,"open":24.16,"prevYearClose":26.98,"prevWeekClose":25.07,"prevMonthClose":25.49,"prevQuarterClose":17.82,"fiveDayClose":25.32,"twentyDayClose":22.18,"sixtyDayClose":17.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"CAI","fiscalQuarterEnding":"2026/06","expectedEps":-0.01,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2026-05-07","symbol":"CAI","fiscalQuarterEnding":"2026/03","expectedEps":-0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2026-02-26","symbol":"CAI","fiscalQuarterEnding":"2025/12","expectedEps":0.01,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2026-01-12","symbol":"CAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CAI","date":"2026-09-11","current":65.430108,"percent":0.786127,"low":-88.150592,"twenty":-40.914563,"median":-30.48612,"eighty":67.251929,"high":165.024421,"avg":1.752433,"sd":72.279973,"marketCap":6793588271},"quantilePoints":[{"date":"2021-09-17","current":9.368604,"twenty":4.110509,"median":11.370572,"eighty":29.049822,"marketCap":968451299},{"date":"2021-09-24","current":9.368604,"twenty":4.156375,"median":11.370572,"eighty":29.049822,"marketCap":968451299},{"date":"2021-10-01","current":9.376989,"twenty":4.213229,"median":11.370724,"eighty":29.050072,"marketCap":969318155},{"date":"2021-10-07","current":9.380344,"twenty":4.238981,"median":11.370724,"eighty":29.050072,"marketCap":969664897},{"date":"2021-10-15","current":9.378667,"twenty":4.266668,"median":11.380332,"eighty":29.050823,"marketCap":969491526},{"date":"2021-10-22","current":9.378667,"twenty":4.284214,"median":11.383933,"eighty":29.120677,"marketCap":969491526},{"date":"2021-10-29","current":9.382021,"twenty":4.305342,"median":11.383933,"eighty":29.120677,"marketCap":969838269},{"date":"2021-11-05","current":9.383698,"twenty":4.32826,"median":11.383933,"eighty":29.120677,"marketCap":970011640},{"date":"2021-11-09","current":6.915273,"twenty":4.340793,"median":11.383933,"eighty":29.120677,"marketCap":961803774},{"date":"2025-06-20","current":-27.445954,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7736739976},{"date":"2025-06-27","current":-26.374479,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7434701838},{"date":"2025-07-03","current":-26.167427,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7376335954},{"date":"2025-07-11","current":-26.246304,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7398570576},{"date":"2025-07-18","current":-30.845816,"twenty":9.382356,"median":19.818182,"eighty":28.465108,"marketCap":8695126991},{"date":"2025-07-25","current":-29.076014,"twenty":9.380344,"median":19.818182,"eighty":28.465108,"marketCap":8196237652},{"date":"2025-08-01","current":-27.685808,"twenty":9.378667,"median":19.818182,"eighty":28.465108,"marketCap":7804352434},{"date":"2025-08-08","current":-28.188649,"twenty":9.377325,"median":19.778051,"eighty":28.363181,"marketCap":7946098151},{"date":"2025-08-15","current":-37.278729,"twenty":9.37397,"median":15.016779,"eighty":28.059445,"marketCap":10402480346},{"date":"2025-08-22","current":-38.41755,"twenty":9.371958,"median":14.936518,"eighty":27.857377,"marketCap":10720263606},{"date":"2025-08-29","current":-38.528408,"twenty":9.368604,"median":14.909765,"eighty":27.685829,"marketCap":10751198260},{"date":"2025-09-05","current":-36.633734,"twenty":9.365249,"median":14.888362,"eighty":27.527351,"marketCap":10222496907},{"date":"2025-09-12","current":-34.47703,"twenty":9.360553,"median":14.824668,"eighty":27.293717,"marketCap":9620677282},{"date":"2025-09-19","current":-33.690942,"twenty":7.38442,"median":14.763781,"eighty":26.71778,"marketCap":9401322465},{"date":"2025-09-26","current":-29.962061,"twenty":-25.851919,"median":14.718778,"eighty":26.293958,"marketCap":8360793206},{"date":"2025-10-03","current":-29.941905,"twenty":-26.165455,"median":11.559155,"eighty":25.35941,"marketCap":8355168724},{"date":"2025-10-10","current":-31.504003,"twenty":-26.421805,"median":11.424439,"eighty":24.232627,"marketCap":8791066116},{"date":"2025-10-17","current":-32.199389,"twenty":-27.275648,"median":11.239535,"eighty":23.200759,"marketCap":8985110761},{"date":"2025-10-24","current":-31.907126,"twenty":-27.85145,"median":10.925198,"eighty":22.717001,"marketCap":8903555765},{"date":"2025-10-31","current":-31.413301,"twenty":-29.076014,"median":10.711237,"eighty":22.474875,"marketCap":8765755945},{"date":"2025-11-07","current":-37.133331,"twenty":-29.570316,"median":10.518408,"eighty":22.474875,"marketCap":6943635775},{"date":"2025-11-14","current":-36.66558,"twenty":-29.872671,"median":10.079921,"eighty":22.474875,"marketCap":6856170228},{"date":"2025-11-21","current":-36.258185,"twenty":-30.266418,"median":9.392084,"eighty":22.474875,"marketCap":6779990559},{"date":"2025-11-28","current":-38.521493,"twenty":-30.494182,"median":9.38873,"eighty":22.474875,"marketCap":7203210944},{"date":"2025-12-05","current":-42.731244,"twenty":-30.709853,"median":9.383698,"eighty":22.390599,"marketCap":7990400859},{"date":"2025-12-12","current":-40.045453,"twenty":-31.411285,"median":9.382021,"eighty":21.98126,"marketCap":7488179336},{"date":"2025-12-19","current":-42.037163,"twenty":-31.770064,"median":9.380344,"eighty":21.917049,"marketCap":7860613274},{"date":"2025-12-26","current":-42.610535,"twenty":-32.023314,"median":9.378667,"eighty":21.917049,"marketCap":7967829105},{"date":"2026-01-02","current":-40.709356,"twenty":-33.019743,"median":9.376989,"eighty":21.917049,"marketCap":7612323982},{"date":"2026-01-09","current":-42.625623,"twenty":-33.660707,"median":9.375312,"eighty":21.911699,"marketCap":7970650574},{"date":"2026-01-16","current":-40.920598,"twenty":-34.325859,"median":9.371958,"eighty":14.957921,"marketCap":7651824551},{"date":"2026-01-23","current":-38.55167,"twenty":-35.122025,"median":9.368604,"eighty":14.936518,"marketCap":7208853882},{"date":"2026-01-30","current":-38.023565,"twenty":-36.062032,"median":9.366927,"eighty":14.901739,"marketCap":7110102459},{"date":"2026-02-06","current":-32.063522,"twenty":-36.001677,"median":9.365249,"eighty":14.891037,"marketCap":5995622113},{"date":"2026-02-13","current":-31.158199,"twenty":-36.001677,"median":9.358541,"eighty":14.824668,"marketCap":5826333959},{"date":"2026-02-20","current":-31.459973,"twenty":-36.001677,"median":6.916509,"eighty":14.791194,"marketCap":5882763344},{"date":"2026-02-27","current":-79.83495,"twenty":-36.095748,"median":-25.920936,"eighty":14.746309,"marketCap":5435802106},{"date":"2026-03-06","current":-79.767155,"twenty":-36.689445,"median":-26.167427,"eighty":11.649494,"marketCap":5431186043},{"date":"2026-03-13","current":-73.417324,"twenty":-37.230355,"median":-26.433637,"eighty":11.50157,"marketCap":4998838767},{"date":"2026-03-20","current":-78.065566,"twenty":-37.948121,"median":-27.000565,"eighty":11.33727,"marketCap":5315328276},{"date":"2026-03-27","current":-76.073463,"twenty":-38.51833,"median":-27.544452,"eighty":11.081046,"marketCap":5179689915},{"date":"2026-04-02","current":-79.393635,"twenty":-38.55167,"median":-28.040754,"eighty":10.896141,"marketCap":5405753850},{"date":"2026-04-10","current":-79.684151,"twenty":-38.689657,"median":-29.080944,"eighty":10.700671,"marketCap":5425534444},{"date":"2026-04-17","current":-84.66441,"twenty":-39.396638,"median":-29.538348,"eighty":10.447088,"marketCap":5764630347},{"date":"2026-04-24","current":-82.156794,"twenty":-39.864388,"median":-29.869713,"eighty":9.998035,"marketCap":5593891765},{"date":"2026-05-01","current":-78.877164,"twenty":-40.407582,"median":-30.254324,"eighty":9.392084,"marketCap":5370588355},{"date":"2026-05-08","current":165.024421,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5608024892},{"date":"2026-05-15","current":126.854033,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4310880598},{"date":"2026-05-22","current":132.593658,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4505930278},{"date":"2026-05-29","current":138.666015,"twenty":-40.929651,"median":-30.496198,"eighty":9.387052,"marketCap":4712287185},{"date":"2026-06-05","current":143.740176,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4884722409},{"date":"2026-06-12","current":149.72935,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5088252510},{"date":"2026-06-18","current":148.564789,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5048677212},{"date":"2026-06-26","current":155.552158,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5286128996},{"date":"2026-07-02","current":155.968073,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5300263031},{"date":"2026-07-10","current":148.647972,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5051504019},{"date":"2026-07-17","current":137.085538,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4658577853},{"date":"2026-07-24","current":130.181352,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4423952876},{"date":"2026-07-31","current":133.841403,"twenty":-40.929651,"median":-30.496198,"eighty":9.387052,"marketCap":4548332382},{"date":"2026-08-07","current":53.756202,"twenty":-40.929651,"median":-30.496198,"eighty":9.389065,"marketCap":5651658300},{"date":"2026-08-14","current":59.618217,"twenty":-40.929651,"median":-30.496198,"eighty":9.397451,"marketCap":6267961225},{"date":"2026-08-21","current":66.069241,"twenty":-40.929651,"median":-30.496198,"eighty":58.231247,"marketCap":6946189671},{"date":"2026-08-28","current":70.907509,"twenty":-40.914563,"median":-30.48612,"eighty":61.166462,"marketCap":7454861006},{"date":"2026-09-04","current":68.058307,"twenty":-40.914563,"median":-30.48612,"eighty":66.649833,"marketCap":7155310109},{"date":"2026-09-11","current":64.617761,"twenty":-40.914563,"median":-30.48612,"eighty":67.251929,"marketCap":6793588271}],"updateTime":1789314108784},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CAI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1144814508","title":"異動解讀｜Caris Life Sciences盤中下跌5.19%，報26.555美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144814508","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144814508?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:27","pubTimestamp":1787758037,"startTime":"0","endTime":"0","summary":"8月26日，Caris Life Sciences盘中下跌5.19%，报26.555美元/股，成交额3942.12万美元。Caris Life Sciences所在的生物科技行业中，个股中，Moderna跌6.87%，安进跌0.46%，艾伯维公司跌1.66%，Revolution Medicines涨0.83%，吉利德科学跌0.15%。Caris Life Sciences, Inc.是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱，致力于通过大规模使用综合分子信息和人工智能/机器学习算法来改变医疗保健，重点聚焦肿瘤学领域。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112064520","title":"異動解讀｜Caris Life Sciences盤中上漲5.01%，報27.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112064520","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112064520?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 00:21","pubTimestamp":1787674886,"startTime":"0","endTime":"0","summary":"8月25日，Caris Life Sciences盘中上涨5.01%，报27.44美元/股，成交额5724.56万美元。Caris Life Sciences所在的生物科技行业中，个股中，Moderna涨11.61%，Natera涨2.01%，安进涨0.24%，艾伯维公司涨0.69%，吉利德科学涨0.78%。Caris Life Sciences, Inc.是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱，致力于通过大规模使用综合分子信息和人工智能/机器学习算法来改变医疗保健，重点聚焦肿瘤学领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159180465","title":"異動解讀｜Caris Life Sciences盤中上漲5.09%，Q2業績大超預期持續推動股價上行","url":"https://stock-news.laohu8.com/highlight/detail?id=1159180465","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159180465?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 22:33","pubTimestamp":1787322781,"startTime":"0","endTime":"0","summary":"8月21日，Caris Life Sciences盘中上涨5.09%，报25.85美元/股，成交额3132.56万美元，延续近期强势表现。消息面上，公司8月5日盘后发布的二季度财报显示，营收2.637亿美元，大幅超出市场一致预期的2.381亿美元，超预期幅度约10.7%。此外，公司近期在产品管线方面持续推进，包括推出PTEN IHC检测拓展转移性前列腺癌精准肿瘤学领域，以及向纽约州提交Caris Assure血液检测授权申请，基本面利好叠加推动市场情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Q2业绩大超预期，Caris Life Sciences盘中上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159838381","title":"異動解讀｜Caris Life Sciences盤中上漲7.89%，Q2業績大超預期持續推動股價上行","url":"https://stock-news.laohu8.com/highlight/detail?id=1159838381","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159838381?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 03:29","pubTimestamp":1787254174,"startTime":"0","endTime":"0","summary":"8月21日，Caris Life Sciences盘中上涨7.89%，报24.555美元/股，成交额1.0亿美元，延续近期强势表现。消息面上，公司8月5日盘后发布的二季度财报显示，营收2.637亿美元，大幅超出市场一致预期的2.381亿美元，超预期幅度约10.7%。此前一季度公司营收同比增长79%至2.162亿美元，全年营收指引维持10亿至10.2亿美元不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Caris Life Sciences大涨，Q2业绩超预期引爆行情","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122482270","title":"財報前瞻｜Caris Life Sciences, Inc.本季度營收預計增長74.08%，機構觀點偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1122482270","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122482270?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 12:31","pubTimestamp":1785299472,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc.将于2026年08月05日发布财报，市场预期公司本季度营收显著改善，盈利能力指标成关注焦点。- 由于未检索到本季度毛利率与净利润或净利率的明确预测数据，相关指标不予展示。多家机构近期对Caris Life Sciences, Inc.的观点偏正面，看多意见占比较高：主流观点认为本季度营收与EBIT的高增速预期建立在订单恢复和合作拓展的基础上，盈利的边际拐点值得跟踪；谨慎观点则提示回款与费用投入的不确定性仍存。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Caris Life Sciences, Inc.本季度营收预计增长74.08%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651910081","title":"Caris Life Sciences推出PTEN IHC檢測拓展轉移性前列腺癌精準腫瘤學","url":"https://stock-news.laohu8.com/highlight/detail?id=2651910081","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651910081?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 23:59","pubTimestamp":1784044740,"startTime":"0","endTime":"0","summary":"Caris Life Sciences今日宣布，正式推出PTEN蛋白免疫组化检测服务，以进一步拓展其在转移性前列腺癌精准肿瘤学领域的解决方案。　　Caris Life Sciences是一家领先的分子科学和人工智能技术公司，致力于通过全面的分子谱分析赋能精准医疗。公司新推出的PTEN IHC检测，是一种基于组织的伴随诊断方法，用于评估前列腺癌患者肿瘤样本中PTEN蛋白的表达水平。　　Caris Life Sciences计划通过其专业的医学事务团队，为临床医生提供关于如何解读和应用PTEN IHC检测结果的教育和支持。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-14/doc-inihuxfz8058037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CAI","BK4092","BK4162","BK4104","CANC","PTEN","IHC","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2641348011","title":"Caris Life Sciences授權1億美元股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2641348011","media":"环球市场播报","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641348011?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 22:35","pubTimestamp":1780929300,"startTime":"0","endTime":"0","summary":"精准医疗公司Caris Life Sciences6月8日宣布，其董事会已授权一项最高达1亿美元的普通股回购计划。Caris计划以现有现金及现金等价物为此次回购提供资金支持。根据公司此前发布的第一季度财报，Caris在2026年第一季度实现总营收2.162亿美元，同比增长79%，其中分子分析服务收入增长85%至2.108亿美元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-08/doc-iniathze8537387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CAI","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101513685","title":"Caris Life Sciences 計劃以可用現金及現金等價物為股票回購計劃提供資金","url":"https://stock-news.laohu8.com/highlight/detail?id=1101513685","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101513685?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 20:33","pubTimestamp":1780921985,"startTime":"0","endTime":"0","summary":"Caris Life Sciences 公司表示，其股票回购计划预计将完全通过现有的现金及现金等价物提供资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122496389","title":"Caris生命科學向紐約州衞生部提交Caris Assure血液檢測授權申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1122496389","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122496389?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 04:08","pubTimestamp":1778270891,"startTime":"0","endTime":"0","summary":"Caris生命科学公司已正式向纽约州卫生部递交申请，旨在为其Caris Assure血液检测技术获取授权许可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118576658","title":"Caris生命科學公司Caris Chromoseq獲Moldx批准，推動髓系惡性腫瘤全面基因組圖譜檢測可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1118576658","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118576658?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 20:32","pubTimestamp":1777897936,"startTime":"0","endTime":"0","summary":"Caris生命科学公司宣布，其Caris Chromoseq检测技术已获得Moldx认证批准。这一重要进展将显著提升髓系恶性肿瘤患者获取全面基因组图谱检测服务的便利性。\n该项认证标志着Caris公司在精准医疗领域迈出关键一步。通过Moldx的权威认可，医疗机构和患者能够更便捷地运用这项先进技术，为髓系恶性肿瘤的精准诊断和治疗方案制定提供有力支持。\nCaris Chromoseq技术的推广应用，将助力临床医生基于个体基因特征制定个性化治疗方案，最终改善髓系恶性肿瘤患者的治疗效果和生活质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160274437","title":"財報前瞻｜Caris Life Sciences, Inc.本季度營收預計按年持平，看多觀點佔優","url":"https://stock-news.laohu8.com/highlight/detail?id=1160274437","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160274437?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 17:05","pubTimestamp":1777539947,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc.将于2026年05月07日盘后发布财报，市场预期本季度营收约2.10亿美元、调整后每股收益约-0.02美元。市场一致预期显示，Caris Life Sciences, Inc.本季度营收预计为2.10亿美元，调整后每股收益预计为-0.02美元；公司层面未给出本季度毛利率与净利润或净利率的量化指引，相关预测数据暂无。公司近期在检测项目上持续扩充：推出用于预测高级别浆液性卵巢癌对铂类化疗耐受风险的AI工具，嵌入Caris AI Insights平台，为临床医生提供风险评分与敏感性预测。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Caris Life Sciences, Inc.本季度营收预计同比持平，看多观点占优","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628273004","title":"華安保險：李雲煥因個人原因辭去公司總經理職務 指定CAI ZHENGYUAN為臨時負責人","url":"https://stock-news.laohu8.com/highlight/detail?id=2628273004","media":"金融一线","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628273004?lang=zh_tw&edition=fundamental","pubTime":"2026-04-17 15:16","pubTimestamp":1776410160,"startTime":"0","endTime":"0","summary":"4月17日金融一线消息，华安财产保险股份有限公司近日公告称，李云焕因个人原因辞去公司总经理职务，根据公司第九届董事会第十次临时会议决议，董事会指定 CAI ZHENGYUAN先生为公司临时负责人，指定期不超过六个月。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王馨茹","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/2026-04-17/doc-inhuutza2283707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","CAI","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627413276","title":"美國研究綜述-百健、Equinix、Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627413276","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627413276?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 15:46","pubTimestamp":1776152774,"startTime":"0","endTime":"0","summary":"美国研究综述-百健、Equinix、Revolution Medicines路透4月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括百健、Equinix 和 Revolution Medicines。要闻 * 百健BIIB.O：Piper Sandler将其评级从中性上调至增持 * Equinix Inc EQIX.O：杰富瑞将目标价从1,000美元上调至1,220美元 * Revolution Medicines Inc RVMD.O：Raymond James将目标价从135美元上调至175美元 * SBA Communications Corp SBAC.O：杰富瑞将目标价从182美元上调至213美元 * Williams Companies Inc WMB.N：Raymond James将目标价从73美元上调至78美元以下是路透周二报道的美国公司研究报告摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4S40X0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBRE","BL","MRNA","NEO","MRNY","TREE","BEX","FLS","MSFX","MSFW","GIS","BEZ","MSFU","MSFT","NSA","EQIX","CAI","LNG","NTRA","BEG","IDYA","ASAN","SJM","DLR","INSP","BE","CPB","MAA","CAG","ADGM","GH","KHC","AVB","HUBS","BIIB","ADPT","BDX","CUBE","BRBR","EXR","MSFD","MKC","PODD","HSY","BSX","CPT","JAN","MRNX","MSFO","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627279413","title":"美國研究綜述-百健、Equinix、Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627279413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627279413?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 15:46","pubTimestamp":1776152774,"startTime":"0","endTime":"0","summary":"美国研究综述-百健、Equinix、Revolution Medicines路透4月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括百健、Equinix 和 Revolution Medicines。要闻 * 百健BIIB.O：Piper Sandler将其评级从中性上调至增持 * Equinix Inc EQIX.O：杰富瑞将目标价从1,000美元上调至1,220美元 * Revolution Medicines Inc RVMD.O：Raymond James将目标价从135美元上调至175美元 * SBA Communications Corp SBAC.O：杰富瑞将目标价从182美元上调至213美元 * Williams Companies Inc WMB.N：Raymond James将目标价从73美元上调至78美元以下是路透周二报导的美国公司研究报告摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4T40X0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SJM","NTRA","HUBS","INSP","NEO","PODD","MSFO","TREE","DLR","MSFT","CPB","LNG","ADPT","BRBR","GIS","KHC","CAI","MSFD","BE","MSFL","ADGM","JAN","NSA","EXR","WGS","CAG","MAA","BEG","BEZ","MKC","BIIB","ASAN","FLS","BL","IDYA","EQIX","MSFW","HSY","AVB","CUBE","GH","MRNA","MSFX","BDX","CPT","BEX","MSFY","BSX","MRNX","CBRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146321171","title":"Caris生命科學公司與Blue Owl Capital及黑石集團達成新信貸協議——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1146321171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146321171?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 04:30","pubTimestamp":1775161821,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会（SEC）的文件显示，Caris生命科学公司（Caris Life Sciences, Inc.）已与Blue Owl Capital及黑石集团（Blackstone）正式签署了一项新的信贷协议。\n该协议的达成标志着Caris生命科学公司在资本结构优化方面迈出关键一步，为其未来的研发投入与业务扩张提供了坚实的资金支持。此次合作也凸显了Blue Owl Capital与黑石集团对生命科学领域创新企业的持续看好。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149391494","title":"Caris生命科學公司信貸協議披露：4億美元定期貸款、3億美元延遲提款及5億美元增量融資","url":"https://stock-news.laohu8.com/highlight/detail?id=1149391494","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149391494?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 04:30","pubTimestamp":1775161820,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会（SEC）文件，Caris生命科学公司（Caris Life Sciences Inc）已达成一项综合性信贷协议。该协议包含三部分核心融资安排：一项4亿美元的定期贷款、一项3亿美元的延迟提款贷款，以及一项高达5亿美元的增量融资额度。\n此项信贷安排显著增强了公司的财务灵活性。定期贷款提供即时资金支持，延迟提款机制允许公司根据未来需求分阶段获取资金，而增量融资额度则为潜在的战略扩张预留了充足空间。\n这一融资动作为Caris生命科学后续的研发投入与业务拓展提供了坚实的资金保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}